» Authors » M Saraheimo

M Saraheimo

Explore the profile of M Saraheimo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 384
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahola A, Harjutsalo V, Forsblom C, Saraheimo M, Groop P
Diabet Med . 2018 Nov; 36(11):1391-1398. PMID: 30426566
Aims: To study the association between dietary intake and glycaemia in Type 1 diabetes. Methods: Data on energy and nutrient intakes, and the mean and coefficient of variation of self-monitored...
2.
Thomas M, Moran J, Harjutsalo V, Thorn L, Waden J, Saraheimo M, et al.
Diabetologia . 2012 Feb; 55(5):1505-13. PMID: 22322918
Aims/hypothesis: Hyperfiltration is widely regarded as a contributing factor to the development of microalbuminuria and progressive nephropathy in type 1 diabetes. However, recent studies have questioned this conclusion. Methods: To...
3.
Ahola A, Harjutsalo V, Saraheimo M, Forsblom C, Groop P
Diabetologia . 2011 Oct; 55(1):73-9. PMID: 22033620
Aims/hypothesis: Individuals with diabetes have increased mortality rates compared with the general population. In patients with type 2 diabetes depression further contributes to the increased mortality. Depression and mortality rates...
4.
Valentine W, Jendle J, Saraheimo M, Thorsteinsson B, Pollock R, Lammert M
Diabet Med . 2011 Sep; 29(3):303-12. PMID: 21951030
Aims: To estimate short-term cost-effectiveness of insulin detemir vs. NPH insulin based on the incidence of mild hypoglycaemia in subjects with Type 1 diabetes in Denmark, Sweden, Finland and the...
5.
Forsblom C, Thomas M, Moran J, Saraheimo M, Thorn L, Waden J, et al.
J Intern Med . 2011 May; 270(4):346-55. PMID: 21615808
Background: Adiponectin is widely regarded as an anti-atherogenic, antioxidant and anti-inflammatory molecule. However, adiponectin concentration is paradoxically increased in individuals with type 1 diabetes, in whom it is positively associated...
6.
Hansen T, Forsblom C, Saraheimo M, Thorn L, Waden J, Hoyem P, et al.
Diabetologia . 2010 Apr; 53(7):1517-24. PMID: 20396997
Aims/hypothesis: Diabetic nephropathy has been associated with low-grade inflammation and activation of the complement system in cross-sectional studies. Data from prospective studies are sparse. We investigated the associations of the...
7.
Tolonen N, Forsblom C, Thorn L, Waden J, Rosengard-Barlund M, Saraheimo M, et al.
Diabetologia . 2009 Oct; 52(12):2522-30. PMID: 19816673
Aims/hypothesis: We studied the impact of baseline lipid variables on the progression of renal disease in a large nationwide prospective cohort of patients with type 1 diabetes. Methods: A total...
8.
Gordin D, Ronnback M, Forsblom C, Makinen V, Saraheimo M, Groop P
Diabetes Res Clin Pract . 2008 Mar; 80(3):e4-7. PMID: 18325620
Aims: Evidence suggests that chronic hyperglycaemia predicts not only microvascular disease but also macrovascular disease, however it is not known whether it is the glucose variability per se or the...
9.
Saraheimo M, Forsblom C, Pettersson-Fernholm K, Flyvbjerg A, Groop P, Frystyk J
Nephrol Dial Transplant . 2007 Nov; 23(3):914-8. PMID: 18003664
Objective: Diabetic nephropathy is associated with low-grade inflammation and activation of the complement system. Defensins, as part of the innate immune system, may play a regulatory role in the complement...
10.
Tolonen N, Forsblom C, Thorn L, Waden J, Rosengard-Barlund M, Saraheimo M, et al.
Diabetologia . 2007 Nov; 51(1):12-20. PMID: 17994214
Aims/hypothesis: We studied the relationship between the lipid profile, estimated GFR (eGFR) and AER in patients with type 1 diabetes. We also assessed the association between the lipid profile and...